7-50134227-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001161834.3(SPATA48):c.848G>A(p.Gly283Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000216 in 1,391,320 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001161834.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPATA48 | NM_001161834.3 | c.848G>A | p.Gly283Glu | missense_variant | 4/9 | ENST00000297001.7 | NP_001155306.3 | |
SPATA48 | XM_011515052.2 | c.848G>A | p.Gly283Glu | missense_variant | 4/8 | XP_011513354.1 | ||
SPATA48 | XM_011515053.3 | c.848G>A | p.Gly283Glu | missense_variant | 4/6 | XP_011513355.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPMIP7 | ENST00000297001.7 | c.848G>A | p.Gly283Glu | missense_variant | 4/9 | 5 | NM_001161834.3 | ENSP00000297001 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000689 AC: 1AN: 145046Hom.: 0 AF XY: 0.0000130 AC XY: 1AN XY: 76850
GnomAD4 exome AF: 0.0000216 AC: 30AN: 1391320Hom.: 0 Cov.: 31 AF XY: 0.0000248 AC XY: 17AN XY: 685988
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 11, 2021 | The c.848G>A (p.G283E) alteration is located in exon 4 (coding exon 4) of the C7orf72 gene. This alteration results from a G to A substitution at nucleotide position 848, causing the glycine (G) at amino acid position 283 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at